These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1274 related articles for article (PubMed ID: 27377924)

  • 21. Comparison of oncological and functional outcomes and quality of life after transanal or laparoscopic total mesorectal excision for rectal cancer: a systematic review and meta-analysis.
    Alimova I; Chernyshov S; Nagudov M; Rybakov E
    Tech Coloproctol; 2021 Aug; 25(8):901-913. PubMed ID: 34002288
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transanal Total Mesorectal Excision in Lower Rectal Cancer: Comparison of Short-Term Outcomes with Conventional Laparoscopic Total Mesorectal Excision.
    Chang TC; Kiu KT
    J Laparoendosc Adv Surg Tech A; 2018 Apr; 28(4):365-369. PubMed ID: 29190178
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pathological outcomes of transanal versus laparoscopic total mesorectal excision for rectal cancer: a systematic review with meta-analysis.
    Jiang HP; Li YS; Wang B; Wang C; Liu F; Shen ZL; Ye YJ; Wang S
    Surg Endosc; 2018 Jun; 32(6):2632-2642. PubMed ID: 29464401
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Meta-analysis of transanal
    Bhattacharya P; Patel I; Fazili N; Hajibandeh S; Hajibandeh S
    World J Gastrointest Surg; 2022 Dec; 14(12):1397-1410. PubMed ID: 36632123
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transanal versus laparoscopic total mesorectal excision for mid and low rectal cancer: a meta-analysis of short-term outcomes.
    Lin D; Yu Z; Chen W; Hu J; Huang X; He Z; Zou YF; Yu X; Guo X; Wu XJ
    Wideochir Inne Tech Maloinwazyjne; 2019 Sep; 14(3):353-365. PubMed ID: 31534564
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Peri-operative, oncological and functional outcomes of robotic versus transanal total mesorectal excision in patients with rectal cancer: A systematic review and meta-analysis.
    Mohamedahmed AYY; Zaman S; Wuheb AA; Ismail A; Nnaji M; Alyamani AA; Eltyeb HA; Yassin NA
    Tech Coloproctol; 2024 Jul; 28(1):75. PubMed ID: 38951249
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Short-term outcomes after transanal and laparoscopic total mesorectal excision for rectal cancer.
    Rasulov AO; Mamedli ZZ; Gordeyev SS; Kozlov NA; Dzhumabaev HE
    Tech Coloproctol; 2016 Apr; 20(4):227-34. PubMed ID: 26794213
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transanal total mesorectal excision (TaTME) versus laparoscopic TME for MRI-defined low rectal cancer: a propensity score-matched analysis of oncological outcomes.
    Roodbeen SX; Penna M; Mackenzie H; Kusters M; Slater A; Jones OM; Lindsey I; Guy RJ; Cunningham C; Hompes R
    Surg Endosc; 2019 Aug; 33(8):2459-2467. PubMed ID: 30350103
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An international multicentre prospective audit of elective rectal cancer surgery; operative approach versus outcome, including transanal total mesorectal excision (TaTME).
    2017 European Society of Coloproctology (ESCP) collaborating group
    Colorectal Dis; 2018 Sep; 20 Suppl 6():33-46. PubMed ID: 30255642
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The application of transanal total mesorectal excision for patients with middle and low rectal cancer: A systematic review and meta-analysis.
    Hu D; Jin P; Hu L; Liu W; Zhang W; Guo T; Yang X
    Medicine (Baltimore); 2018 Jul; 97(28):e11410. PubMed ID: 29995787
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Our experience with transanal total mesorectal excision (TaTME) procedures in middle and distal rectal tumors.
    Procházka V; Grolich T; Farkašová M; Čan V; Svatoň R; Svoboda M; Ostřížková L; Eid M; Frola L; Bohatá Š; Kala Z
    Rozhl Chir; 2020; 99(3):124-130. PubMed ID: 32349496
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of early experience of robotic and transanal total mesorectal excision using propensity score matching.
    Law WL; Foo DCC
    Surg Endosc; 2019 Mar; 33(3):757-763. PubMed ID: 30014329
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Efficacy meta-analysis of laparoscope-assisted transanal total mesorectal excision and conventional laparoscopic excision for rectal cancer].
    Zhen Y; Xiao R; Shi H; Huo S; Xu Z
    Zhonghua Wei Chang Wai Ke Za Zhi; 2016 Jun; 19(6):702-7. PubMed ID: 27353108
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A systematic review of transanal total mesorectal excision: is this the future of rectal cancer surgery?
    Simillis C; Hompes R; Penna M; Rasheed S; Tekkis PP
    Colorectal Dis; 2016 Jan; 18(1):19-36. PubMed ID: 26466751
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Three-Year Nationwide Experience with Transanal Total Mesorectal Excision for Rectal Cancer in the Netherlands: A Propensity Score-Matched Comparison with Conventional Laparoscopic Total Mesorectal Excision.
    Detering R; Roodbeen SX; van Oostendorp SE; Dekker JT; Sietses C; Bemelman WA; Tanis PJ; Hompes R; Tuynman JB;
    J Am Coll Surg; 2019 Mar; 228(3):235-244.e1. PubMed ID: 30639298
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transanal total mesorectal excision (taTME) for rectal cancer: a training pathway.
    McLemore EC; Harnsberger CR; Broderick RC; Leland H; Sylla P; Coker AM; Fuchs HF; Jacobsen GR; Sandler B; Attaluri V; Tsay AT; Wexner SD; Talamini MA; Horgan S
    Surg Endosc; 2016 Sep; 30(9):4130-5. PubMed ID: 26659246
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transanal total mesorectal excision (taTME) in a single-surgeon setting: refinements of the technique during the learning phase.
    Caycedo-Marulanda A; Ma G; Jiang HY
    Tech Coloproctol; 2018 Jun; 22(6):433-443. PubMed ID: 29956003
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Comparison of postoperative bowel function between patients undergoing transanal and laparoscopic total mesorectal excision].
    Dou R; Sun W; Luo S; Hou Y; Zhang C; Kang L
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Mar; 22(3):246-254. PubMed ID: 30919377
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transanal versus laparoscopic total mesorectal excision for mid and low rectal cancer (Ta-LaTME study): multicentre, randomized, open-label trial.
    Serra-Aracil X; Zarate A; Bargalló J; Gonzalez A; Serracant A; Roura J; Delgado S; Mora-López L;
    Br J Surg; 2023 Jan; 110(2):150-158. PubMed ID: 36224406
    [TBL] [Abstract][Full Text] [Related]  

  • 40. COLOR III: a multicentre randomised clinical trial comparing transanal TME versus laparoscopic TME for mid and low rectal cancer.
    Deijen CL; Velthuis S; Tsai A; Mavroveli S; de Lange-de Klerk ES; Sietses C; Tuynman JB; Lacy AM; Hanna GB; Bonjer HJ
    Surg Endosc; 2016 Aug; 30(8):3210-5. PubMed ID: 26537907
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 64.